Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

EKTAB:SS

81.250 SEK 4.300 5.03%

As of 11:30:00 ET on 03/04/2015.

Snapshot for Elekta AB (EKTAB)

Open: 78.700 Day's Range: 77.250 - 81.250 Volume: 11,446,164
Previous Close: 85.550 52wk Range: 63.950 - 94.711 1-Yr Rtn: +0.11%

Stock Chart for EKTAB

No chart data available.
  • EKTAB:SS 81.250
  • 1D
  • 1M
  • 1Y
85.550
Interactive EKTAB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EKTAB

Current P/E Ratio (ttm) 30.2045
Estimated P/E(04/2015) 21.5803
Relative P/E vs. OMX 1.6910
Earnings Per Share (SEK) (ttm) 2.6900
Est. EPS (SEK) (04/2015) 3.7650
Est. PEG Ratio 1.7699
Market Cap (M SEK) 31,104.84
Shares Outstanding (M) 368.58
30 Day Average Volume 1,726,319
Price/Book (mrq) 4.9798
Price/Sale (ttm) 2.8397
Dividend Indicated Gross Yield 1.85%
Cash Dividend (SEK) 1.5000
Dividend Ex-Date 08/29/2014
5 Year Dividend Growth 31.95%
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EKTAB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for EKTAB

Elekta AB produces and sells advanced medical products for treatment of neurological disorders and radiation of cancer. The Company has developed the Gamma Knife, a non-invasive surgical tool for the management of small and hard to locate intracranial lesions, as well as a complete system for stereotactic neurosurgery. Elekta markets worldwide.

Laurent LeksellChairman/FounderNiklas SavanderPresident/CEO
Johan SedihnChief Operating OfficerHakan BergstromChief Financial Officer
More Company Profile & Key Executives for EKTAB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil